Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protection Against Severe Coronavirus Disease 2019 Following in Patients With Multiple Sclerosis Statified According to Disease Modifying Treatment

NCT05834335 is registered in ClinicalTrials.gov with National MS Center Melsbroek as lead sponsor.

NCT NCT05834335
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05834335 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protection Against Severe Coronavirus Disease 2019 Following in Patients With Multiple Sclerosis Statified According to Disease Modifying Treatment
Lead sponsor
National MS Center Melsbroek
Phase
Observational
Overall status
Completed
Start date
March 1, 2020
Completion date
April 1, 2023
Enrollment
400 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis